Aktis Oncology, Inc.AKTSNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank50
Studio
Year-over-Year Change

Return on invested capital

Latest
-16.86%
↑ 17% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-20.40%
Historical baseline
PeriodValueYoY Change
2024-16.86%+43.0%
2023-29.58%-100.4%
2022-14.76%-